1 |
Allison, A.C. and E.M. Eugui. 1999. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47, 85-118.
|
2 |
Diamond, M.S., M. Zachariah, and E. Harris. 2002. Mycophenolic acid inhibits Dengue virus infection by preventing replication of viral RNA. Virology 304, 211-221.
DOI
ScienceOn
|
3 |
DIFCO manual.1995. Dehydrated culture media and reagents for microbiology 11th ed., Difco Laboratories, Detroit, USA.
|
4 |
Dipchand, A.I., B. Pietra, B.W. McCrindle, H.L. Rosebrook- Bicknell, and M.M. Boucek. 2001. Mycopheolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil. J. Heart Lung Transplant. 20, 1035-1043.
DOI
ScienceOn
|
5 |
Doerfler, D.L., C.D. Bartman, and I.M. Campbell. 1979. Mycophenolic acid production by Penicillium brevicompactum in two media. Microbiology 25, 940-943.
|
6 |
Fulton, B. and A. Markham. 1996. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs 51, 278-298.
DOI
ScienceOn
|
7 |
Jonsson, C.A. and H. Carlsten. 2002. Mycophenolic acid inhibits inosine 5′-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages. Cell. Immunol. 216, 93-101.
DOI
ScienceOn
|
8 |
Kida, T., T. Ishikawa, and H. Shibai. 1981. Method for production of mycophenolic acid by fermentation. U.S. Patent. 4,452,891.
|
9 |
Lafont, P., J.P. Debeaupuis, E.M. Gaillaardin, and J. Payen. 1979. Production of mycophenolic acid by Penicillium roqueforti strains. Appl. Environ. Microbiol. 37, 365-368.
|
10 |
Lee, B.K., J.K. Kim, H.I. Kang, and J.W. Lee. 2001. Enhanced production of avermectin B1a with Streptomyces avermitilis by optimization of medium and glucose feeding. Kor. J. Microbiol. 37(2), 158-163.
|
11 |
Mele, T.S. and P.F. Halloran. 1999. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 47, 215-245.
|
12 |
Na-Bangchang K., O. Supasyndh, T. Supaporn, V. Banmairuroi, and J. Karbwang. 1999. Simple and sensitive high-performance liquid chromatographic method for the determination of mycophenolic acid in plasma. J. Chromatogr. B 738, 169-173.
|
13 |
Peter J.H., S. Gregoor, T.V. Gelder, and W. Weimar. 2000. Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine. Nether. J. Med. 57, 233-246.
DOI
ScienceOn
|
14 |
Sadhukhan, A.K., M.V.R. Murthy, R.A. Kumar, E.V.S. Mohan, G. Vandana, C. Bhar, and K.V. Rao. 1999. Optimization of mycophenolic acid production in solid state fermentation using response surface methodology. J. Ind. Microbiol. Biotechnol. 22, 33-38.
DOI
ScienceOn
|
15 |
Pirsch, J.D. and H.W. Sollinger. 1996. Mycophnolate mofetilclinical and experimental experience. Ther. Drug Monit. 18, 357-361.
DOI
ScienceOn
|
16 |
Queener S.W. and C.H. Nash II. 1978. Procedure for obtaining Penicillium species mutants with improved ability to synthesize mycophenolic acid. U.S. Patent 4,115,197.
|
17 |
Ransom, J.T. 1995. Mechanism of action of mycophenolate mofetil. Ther. Drug Monit. 17, 681-684.
DOI
ScienceOn
|
18 |
Stanbury, P.F., A. Whitaker, and S.J. Hall. 1999. Principles of fermentation technology, 2nd ed., p. 175-177. Butterworth- Heinemann, Oxford, UK.
|
19 |
Yalowitz, J.A., K. Pankiewicz, S.E. Patterson, and H.N. Jayaram. 2002. Cytotoxicity and cellular differentiation activity of methylenebis (phosphonate) analogs of tiazofurin and mycophenolic acid adenine dinucleotide in human cancer cell line. Cancer Lett. 181, 31-38.
DOI
ScienceOn
|